Portland, OR, Sept. 25, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global radiodermatitis market generated $477.48 million in 2019, and is projected to hit $609.68 million by 2027, registering a CAGR of 4.1% from 2020 to 2027.
Increase in the geriatric population, rise in prevalence of cancer, and surge in adoption of radiotherapy drive the growth of the global radiodermatitis market. However, higher radiodermatitis cost hinders the market. On the other hand, reduction of side effected related to radiation therapy are anticipated to open new opportunities for the market players in the future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4498
Covid-19 scenario:
- The demand for radiodermatitis is anticipated to reduce during the Covid-19 pandemic, owing to several manufacturers of radiodermatitis that have been suffering from the challenges in the supply of their products.
- The patients suffering from the Covid-19 are now treated as a high-risk group as they need frequent hospital visits for radiation therapy.
The global radiodermatitis market is segmented on the basis of product, distribution channel, and region. Based on product, the market is divided into topical, oral drugs, and dressings. The dressing segment would manifest the highest CAGR of 5.0% during the study period. However, the topical segment dominated the market in 2019, contributing to more than four-fifths of the market.
On the basis of distribution channel, the marketis classified into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment held the lion’s share in 2019, accounting for more than three-fifths of the market. However, the online pharmacy segment is anticipated to register the highest CAGR of 5.0% from 2020 to 2027.
The global radiodermatitis market is analyzed across various regions such as North America, LAMEA, Asia-Pacific, and Europe. The market across Asia-Pacific held the largest share in 2019, contributing to more than two-fifths of the market. However, the market across North America is projected to portray the highest CAGR of 5.1% during the study period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4498
The global radiodermatitis market report includes an in-depth analysis of the major market players such as Bausch Health Companies Inc, BMG Pharma SPA, Convatec Group Plc, Helsinn Healthcare SA, Mylan N.V., 3M Company, Bayer Ag, GlaxoSmithKline, Molnlycke Health Care, Smith & Nephew Plc, and Stratpharma Ag.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying :https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Drug Delivery Devices Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
Digital Pathology Market - Global Opportunity Analysis and Industry Forecast, 2018–2026
Uveitis Treatment Market-Global Opportunity Analysis and Industry Forecast, 2019–2026
Disposable Gloves Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Pharmaceutical Filtration Market -Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, and researchers and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.